Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huiying Qiu

Showing results (21-30 of 194) with videos related to

Pageof 20
Sort By:
Cancer Genetics and Cytogenetics|December 16, 2010
A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemiaJinlan Pan, Yongquan Xue, Huiying Qiu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 26, 2015
[The prognostic value of early BCR-ABL transcripts level in 251 patients with chronic myeloid leukemia after treatment with imatinib]Xiebing Bao, Huiying Qiu, Suning Chen, et al.
International Journal of Hematology|December 17, 2008
Bortezomib in combination with epirubicin, dexamethasone and thalidomide is a highly effective regimen in the treatment of multiple myeloma: a single-center experienceShuqing Lü, Jianmin Wang, Xiaoqian Xu, et al.
International Journal of Hematology|February 22, 2008
Allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in second chronic phase attained by imatinib after onset of blast crisisYing Wang, Depei Wu, Aining Sun, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|March 27, 2023
[Analysis of epigenetic modification gene mutations among patients with acute myeloid leukemia]Jifeng Wei, Huiying Qiu, Hang Zhou, et al.
International Immunopharmacology|September 26, 2018
MYD88 L265P mutation promoted malignant B cell resistance against T cell-mediated cytotoxicity via upregulating the IL-10/STAT3 cascadeHuiying Qiu, Shenglan Gong, Lili Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 26, 2015
[Efficacy observation of tigecycline in the treatment of 107 patients with infection due to granulocytopenia]Xingxing Hu, Aining Sun, Jiajia Zheng, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 26, 2016
[Clinical risks analysis of EBV infection in patients with allogeneic hematopoietic stem cell transplantation]Xiebing Bao, Qian Zhu, Huiying Qiu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 25, 2014
[Clinical characteristics and prognoses of 167 acute erythroleukemia patients]Wenxiu Cheng, Aining Sun, Suning Chen, et al.
Anti-Cancer Drugs|May 4, 2023
Gilteritinib-induced severe immune-related enteritis: a possible case reportPan Luo, Huiying Qiu, Yushan Yang, et al.
Pageof 20

Showing results (21-30 of 194) with videos related to

Sort By:
Pageof 20
Cancer Genetics and Cytogenetics|December 16, 2010
A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemiaJinlan Pan, Yongquan Xue, Huiying Qiu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 26, 2015
[The prognostic value of early BCR-ABL transcripts level in 251 patients with chronic myeloid leukemia after treatment with imatinib]Xiebing Bao, Huiying Qiu, Suning Chen, et al.
International Journal of Hematology|December 17, 2008
Bortezomib in combination with epirubicin, dexamethasone and thalidomide is a highly effective regimen in the treatment of multiple myeloma: a single-center experienceShuqing Lü, Jianmin Wang, Xiaoqian Xu, et al.
International Journal of Hematology|February 22, 2008
Allogeneic hematopoietic stem cell transplantation for patients with chronic myeloid leukemia in second chronic phase attained by imatinib after onset of blast crisisYing Wang, Depei Wu, Aining Sun, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|March 27, 2023
[Analysis of epigenetic modification gene mutations among patients with acute myeloid leukemia]Jifeng Wei, Huiying Qiu, Hang Zhou, et al.
International Immunopharmacology|September 26, 2018
MYD88 L265P mutation promoted malignant B cell resistance against T cell-mediated cytotoxicity via upregulating the IL-10/STAT3 cascadeHuiying Qiu, Shenglan Gong, Lili Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 26, 2015
[Efficacy observation of tigecycline in the treatment of 107 patients with infection due to granulocytopenia]Xingxing Hu, Aining Sun, Jiajia Zheng, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 26, 2016
[Clinical risks analysis of EBV infection in patients with allogeneic hematopoietic stem cell transplantation]Xiebing Bao, Qian Zhu, Huiying Qiu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|November 25, 2014
[Clinical characteristics and prognoses of 167 acute erythroleukemia patients]Wenxiu Cheng, Aining Sun, Suning Chen, et al.
Anti-Cancer Drugs|May 4, 2023
Gilteritinib-induced severe immune-related enteritis: a possible case reportPan Luo, Huiying Qiu, Yushan Yang, et al.
Pageof 20